
GC17012
MK3102
Also known as (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine
MK3102 (Omarigliptin) is a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor (IC50: 2·2 nM) developed for the treatment of type 2 diabetes
ChemicalCAS1226781-44-7MW398.43FormulaC17H20F2N4O3S
- CAS number
- 1226781-44-7
- Molecular weight
- 398.43
- Formula
- C17H20F2N4O3S
- Solubility
- ≥ 17·15mg/mL in DMSO
- InChIKey
- MKMPWKUAHLTIBJ-ISTRZQFTSA-N
- Catalogue number
- GC17012
- Brand
- GLPBIO
Computed properties PubChem CID 46209133 · XLogP 0.3 · TPSA 98.8 Ų · H-bond donors 1
- XLogP
- 0.3
- TPSA
- 98.8 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 3
- Heavy atoms
- 27
SMILES CS(=O)(=O)N1C=C2CN(CC2=N1)[C@@H]3C[C@@H]([C@H](OC3)C4=C(C=CC(=C4)F)F)N
Computed descriptors from PubChem (CID 46209133), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il